RS

Rojaline Sahoo

Active Director Director DIN 07657653
DIN 07657653 First appointment Nov 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value •••• Premium profile

About Rojaline Sahoo

Data last updated:

Rojaline Sahoo is a Director at Dermonova Pharma Private Limited (since 2016). The company operates in Pharma. Dermonova Pharma Private Limited reported revenue of ₹4.14 Cr (FY 2025).

DIN 07657653
Primary Designation Director
Industry Pharma
First Appointment 16 Nov 2016
Oldest Company Age 10 yrs
Largest company Dermonova Pharma Private Limited · ₹4.14 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dermonova Pharma Private Limited U24290MH2016PTC282685
Director16 Nov 20162016₹4.14 Cr (FY 2025)Active

Board colleagues of Rojaline Sahoo

NameDINCompanyDesignation
Rakesh Kumar Sahoo07545986Dermonova Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dermonova Pharma Private Limited
Premium access

Shareholding and investment profile for Rojaline Sahoo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rojaline Sahoo

Rojaline Sahoo currently holds 1 directorship: Dermonova Pharma Private Limited (Director, since 16 Nov 2016, revenue ₹4.14 Cr (FY 2025)).

Rojaline Sahoo was first appointed on 16 Nov 2016 as Director at Dermonova Pharma Private Limited.

The current boards of Rojaline Sahoo's companies include Rakesh Kumar Sahoo (Dermonova Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available